Groeneveld, Geert HMarbus, Sierk DIsmail, Noorde Vries, Jutte J CSchneeberger, PeterOosterheert, Jan Jelrikvan Dissel, Jaap Tde Boer, Mark G J2020-09-272020-09-272020-09-061872-79133289868510.1016/j.ijantimicag.2020.106155http://hdl.handle.net/10029/624384eninfo:eu-repo/semantics/closedAccessComplicationsInfluenzaMortalityOseltamivirTreatmentEffectiveness of oseltamivir in reduction of complications and 30-day mortality in severe seasonal influenza infection.ArticleInt J Antimicrob Agents 2020; 56(5):106155